KALVISTA PHARMA Cash Flow - Quarterly (NASDAQ:KALV)

Add to My Stocks
$18 $1.74 (10.7%) KALV stock closing price Sep 20, 2018 (Closing)

The KALVISTA PHARMA cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about KALVISTA PHARMA profits and KALVISTA PHARMA debt. This statement can tell if a company is running out of money while still being profitable and is useful in KALVISTA PHARMA stock analysis. KALVISTA PHARMA had a negative net income cash flow of $-15.81M till this quarter of 2018 Q4. This report is very useful in measuring the short term viability of a company. KALVISTA PHARMA has a positive cash and cash equivalents change of $20.11M.

View and download details of KALVISTA PHARMA cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is May - Apr2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Net Income Cash Flow
-15.81M-15.14M-9.91M-4.92M-18.6M-14.4M-6.75M-3.43M-11.43M-6.25M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities25.77M31.25M-2.39M--4.18M-5.47M-1.46M-0.83M-0.21M-2.32M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-----0.97M-1.23M-1.63M-1.39M-1.54M-2.21M
Net Cash from (used by) Operating Activities
10.56M16.51M-11.7M-4.44M-23.72M-21.08M-9.84M-5.65M-13.15M-10.76M
Increase (Decrease) in Prop Plant And Equipment-1.43M-0.34M-0.16M-0.11M-0.07M-0.06M-0.06M-0.04M-0.01M-0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----34.13M34.13M----
Net Cash from (used by) Investment Activities
-1.43M-0.34M-0.16M-0.11M34.06M34.07M-0.06M-0.04M-0.01M-0.01M
Issuance (Purchase) of Equity Shares9.14M9.1M9.1M-----33M33M
Issuance (Repayment) of Debt Securities-0.15M-0.1M-0.04M-------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
8.99M8.99M9.05M-----33M33M
Effect of Exchange Rate Changes on Cash1.99M2.55M-0.01M--1.15M-1.25M-1.17M-0.44M-0.59M-0.58M
Net Change in Cash & Cash Equivalents
20.11M27.72M-2.82M-4.49M9.18M11.73M-11.07M-6.13M19.23M21.64M
Cash & Equivalents at Beginning of Year30.95M21.76M2.52M-9.78M-----
Cash & Equivalents at Year End51.06M58.67M28.12M26.45M30.95M33.49M10.68M15.62M21.76M24.16M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Durect financial analysis

While KALVISTA PHARMA stock price history provides the price history of a stock, KALVISTA PHARMA stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • KALVISTA PHARMA saw a negative change in Net Change in Cash and Cash Equivalents of $20.11M till 2018 Q4. Apart from the KALVISTA PHARMA stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • KALVISTA PHARMA increased its cash from operating activities to $10.56M till 2018 Q4. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a negative value of $-1.43M for KALV stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. KALVISTA PHARMA earned $8.99M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For KALVISTA PHARMA Cash Flow

FCF margin
0

Quarterly Cash Flow Statements For KALVISTA PHARMA Peers

ALLERGY THERAPT cash flow, Durect cash flow, ZOMEDICA PHARMA cash flow, Zynex cash flow